Belluscura withdraws guidance
By HME News Staff
Updated 11:09 AM CDT, Wed April 9, 2025
LONDON – Belluscura has withdrawn their previous market guidance for the current year ending Dec. 31, 2025, because of the potential financial implications, risks and opportunities of tariffs on imports to the United States. The company is currently assessing, in particular, the 54% tariff (previously 20%) for goods imported from China, in which a significant proportion of the company's portable oxygen concentrators, raw materials and component parts are currently manufactured. Belluscura says it expects to make a further announcement once it has been able to better assess the situation, including possible subsequent developments.
Comments